A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto General Research Institute, Toronto, Ontario, Canada.
Journal of Clinical Investigation (Impact Factor: 13.22). 06/2001; 107(10):1255-62. DOI: 10.1172/JCI11871
Source: PubMed


VCAM-1 and ICAM-1 are endothelial adhesion molecules of the Ig gene superfamily that may participate in atherogenesis by promoting monocyte accumulation in the arterial intima. Both are expressed in regions predisposed to atherosclerosis and at the periphery of established lesions, while ICAM-1 is also expressed more broadly. To evaluate functions of VCAM-1 in chronic disease, we disrupted its fourth Ig domain, producing the murine Vcam1(D4D) allele. VCAM-1(D4D) mRNA and protein were reduced to 2-8% of wild-type allele (Vcam1(+)) levels but were sufficient to partially rescue the lethal phenotype of VCAM-1-null embryos. After crossing into the LDL receptor-null background, Vcam1(+/+) and Vcam1(D4D/D4D) paired littermates were generated from heterozygous intercrosses and fed a cholesterol-enriched diet for 8 weeks. The area of early atherosclerotic lesions in the aorta, quantified by en face oil red O staining, was reduced significantly in Vcam1(D4D/D4D) mice, although cholesterol levels, lipoprotein profiles, and numbers of circulating leukocytes were comparable to wild-type. In contrast, deficiency of ICAM-1 either alone or in combination with VCAM-1 deficiency did not alter nascent lesion formation. Therefore, although expression of both VCAM-1 and ICAM-1 is upregulated in atherosclerotic lesions, our data indicate that VCAM-1 plays a dominant role in the initiation of atherosclerosis.

Download full-text


Available from: Su-Ning Zhu, Nov 18, 2015
  • Source
    • " ] . While elevated ECAM expression is important for a normal inflammatory response , the ECAMs can be aberrantly expressed and contribute to pathological inflamma - tion ( Luscinskas and Gimbrone , 1996 ) . For example , VCAM - 1 has been implicated in many inflammatory diseases such as athero - sclerosis , and arthritis ( Carter et al . , 2002 ; Cybulsky et al . , 2001 ) . Thus , compounds which inhibit cytokine - induced VCAM - 1 expres - sion could aid in treating pathological inflammation . Methimazole [ 3 - methyl - 1 , 3 imidazole - 2 thione ( MMI ) ] is routinely used clini - cally for the treatment of Graves ' disease ( Giuliani et al . , 2010 ) and patients treated with MMI have decreased leve"
    [Show abstract] [Hide abstract]
    ABSTRACT: The expression of vascular cell adhesion molecule-1 (VCAM-1) on the vascular endothelium can be increased by pro-inflammatory cytokines [e.g. tumor necrosis factor – α (TNF-α)]. VCAM-1 contributes to leukocyte adhesion to, and emigration from, the vasculature which is a key aspect of pathological inflammation. As such, a promising therapeutic approach for pathological inflammation is to inhibit the expression of VCAM-1. Methimazole [3-methyl-1, 3 imidazole-2 thione (MMI)] is routinely used for the treatment of Graves' disease and patients treated with MMI have decreased levels of circulating VCAM-1. In this study we used cultured human umbilical vein endothelial cells (HUVEC) to investigate the effect of MMI structural modifications on TNF-α induced VCAM-1 expression. We found that addition of a phenyl ring at the 4-nitrogen of MMI yields a compound that is significantly more potent than MMI at inhibiting 24 h TNF-α-induced VCAM-1 protein expression. Addition of a para methoxy to the appended phenyl group increases the inhibition while substitution of a thiazole ring for an imidazole ring in the phenyl derivatives yields no clear difference in inhibition. Addition of the phenyl ring to MMI appears to increase toxicity as does substitution of a thiazole ring for an imidazole ring in the phenyl MMI derivatives. Each of the compounds reduced TNF-α-induced VCAM-1 mRNA expression and had a functional inhibitory effect, i.e. each inhibited monocytic cell adhesion to 24 h TNF-α-activated HUVEC under fluid flow conditions. Combined, these studies provide important insights into the design of MMI-related anti-inflammatory compounds.
    European Journal of Pharmacology 01/2015; 751. DOI:10.1016/j.ejphar.2015.01.032 · 2.53 Impact Factor
  • Source
    • "The relationship between neointimal formation and cell adhesion molecules, as well as the accumulation of inflammatory cells has been well established in a number of previous studies.1,24–27 Indeed, deficiency of cell adhesion molecules such as Vcam1 has been shown to decrease neointimal formation,25–27 as well as to decrease the accumulation of monocytes/macrophages in atherosclerotic lesions.26 The infiltrated inflammatory cells stimulate SMC proliferation in a paracrine manner. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Krüppel-like factor 4 (Klf4) is involved in a variety of cellular functions by activating or repressing the transcription of multiple genes. Results of previous studies showed that tamoxifen-inducible global deletion of the Klf4 gene in mice accelerated neointimal formation following vascular injury, in part via enhanced proliferation of smooth muscle cells (SMCs). Because Klf4 is also expressed in non-SMCs including endothelial cells (ECs), we determined if Tie2 promoter-dependent deletion of Klf4 in ECs and hematopoietic cells affected injury-induced neointimal formation. Klf4 conditional knockout (cKO) mice were generated by breeding Tie2-Cre mice and Klf4 floxed mice, and their phenotype was analyzed after carotid ligation injury. Results showed that injury-induced repression of SMC differentiation markers was unaffected by Tie2 promoter-dependent Klf4 deletion. However, of interest, neointimal formation was significantly enhanced in Klf4-cKO mice 21 days following carotid injury. Moreover, Klf4-cKO mice exhibited an augmented proliferation rate, enhanced accumulation of macrophages and T lymphocytes, and elevated expression of cell adhesion molecules including vascular cell adhesion molecule-1 (Vcam1) and E-selectin in injured arteries. Mechanistic analyses in cultured ECs revealed that Klf4 inhibited tumor necrosis factor-α-induced expression of Vcam1 through blocking the binding of nuclear factor-κB to the Vcam1 promoter. These results provide evidence that Klf4 in non-SMCs such as ECs regulates neointimal formation by repressing arterial inflammation following vascular injury.
    Journal of the American Heart Association 12/2014; 3(1):e000622. DOI:10.1161/JAHA.113.000622 · 4.31 Impact Factor
  • Source
    • "The adhesion of circulating monocytes to intimal endothelial cells is thought to be one of the earliest events in atherosclerogenesis229. Subsequently, monocytes attached to endothelial cells invade the vascular wall and play a pivotal role in the inflammatory response in the vasculature30. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A relationship between periodontal disease and atherosclerosis has been suggested by epidemiological studies. Ligature-induced experimental periodontitis is an adequate model for clinical periodontitis, which starts from plaque accumulation, followed by inflammation in the periodontal tissue. Here we have demonstrated using a ligature-induced periodontitis model that periodontitis activates monocytes/macrophages, which subsequently circulate in the blood and adhere to vascular endothelial cells without altering the serum TNF-α concentration. Adherent monocytes/macrophages induced NF-κB activation and VCAM-1 expression in the endothelium and increased the expression of the TNF-α signaling cascade in the aorta. Peripheral blood-derived mononuclear cells from rats with experimental periodontitis showed enhanced adhesion and increased NF-κB/VCAM-1 in cultured vascular endothelial cells. Our results suggest that periodontitis triggers the initial pathogenesis of atherosclerosis, inflammation of the vasculature, through activating monocytes/macrophages.
    Scientific Reports 05/2014; 4. DOI:10.1038/srep05171 · 5.58 Impact Factor
Show more